The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Are The Forecasted Market Size Figures For The Medical Device Clinical Trials Market In 2026 And 2030?
The medical device clinical trials market size has seen significant expansion in recent years. This market is set to increase from $18.07 billion in 2025 to $19.36 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.2%. Factors contributing to its historical growth include advances in medical device innovation, rigorous regulatory approval processes, a heightened need for patient safety validation, the broadening scope of hospital-based clinical research, and increased investment in the generation of clinical evidence.
The medical device clinical trials market is anticipated to show robust growth in the coming years. Its value is forecast to reach $25.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This projected growth is driven by several factors, including the proliferation of wearable and connected medical devices, heightened regulatory oversight concerning device performance, the broadening of digital trial platforms, a surge in remote patient monitoring utilization within trials, and the expanding globalization of clinical research. Key developments expected during this period encompass the wider embrace of decentralized clinical trials, a greater reliance on real-world evidence in device evaluations, an increased emphasis on post-market approval and prolonged safety investigations, the development of adaptive and hybrid trial methodologies, and a heightened need for trial management that adheres strictly to regulations.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp
What Primary Factors Are Fueling The Expansion Of The Medical Device Clinical Trials Market?
The increasing occurrence of chronic diseases is anticipated to stimulate the expansion of the medical device clinical trials market in the future. Chronic diseases are enduring health issues characterized by gradual progression and requiring continuous medical oversight. The proliferation of these conditions is attributable to increasingly inactive lifestyles, involving extended periods of sitting or device usage, which diminishes calorie burning and compromises cardiovascular well-being, contributing to conditions like obesity, diabetes, and hypertension. This rise in chronic diseases consequently necessitates medical device clinical trials to create and substantiate advanced devices for precise diagnosis, successful treatment, and overall management. Illustratively, in June 2023, the US-based public health research institute, the Institute for Health Metrics and Evaluation, disclosed that over half a billion individuals worldwide suffered from diabetes. This figure is projected to exceed twice its current size, reaching 1.3 billion people by the year 2050. Hence, the growing prevalence of chronic diseases serves as a key driver for the growth of the medical device clinical trials market.
Which Segment-Based Categories Are Covered In The Medical Device Clinical Trials Market?
The medical device clinical trials market covered in this report is segmented –
1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study
2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications
3) By Study Design: Interventional, Observational, Expanded Access
Subsegments:
1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing
2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials
3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies
4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies
Which Trends Are Affecting The Medical Device Clinical Trials Market Framework?
Major companies operating in the medical device clinical trials market are focusing on the development of AI-driven medical device software to optimize clinical trial protocols and resource allocation, thereby enhancing trial efficiency and reducing costs. AI-powered medical device software describes healthcare software that leverages artificial intelligence (AI) algorithms, specifically machine learning or deep learning, to support or automate medical tasks. For instance, in January 2025, Risklick, a Switzerland-based pharmaceutical firm, launched Protocol AI, an AI-based software engineered to accelerate and optimize clinical trials for medical devices. Protocol AI utilizes Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, facilitating the automatic drafting of clinical trial protocols within minutes. This innovation significantly cuts down the time and expense required for protocol development, a process that traditionally takes about six months, and has already demonstrated up to a 50% reduction in document development time for medicinal products.
Who Are The Leading Firms Participating In The Medical Device Clinical Trials Market?
Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG
Access The Complete Medical Device Clinical Trials Market Report:
Which Geographic Region Represents The Largest Medical Device Clinical Trials Market Share?
North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Medical Device Clinical Trials Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp
Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2026, By The Business Research Company
Clinical Trial Supplies Market Report 2026
https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report
Virtual Clinical Trials Market Report 2026
https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report
Medical Device Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model